鲁抗医药(600789.SH)：盐酸伐地那非片获得药品注册证书

Core Viewpoint - The company, LuKang Pharmaceutical (600789.SH), announced that its subsidiary, Shandong LuKang Pharmaceutical Group Saiter Co., Ltd., received a drug registration certificate from the National Medical Products Administration for Vardenafil Hydrochloride Tablets, marking it as a generic drug approved under the new registration category 4, which has passed the consistency evaluation of quality and efficacy for generic drugs [1] Group 1 - The drug Vardenafil Hydrochloride Tablets is a phosphodiesterase inhibitor that enhances blood flow to the penis by inhibiting the degradation of cyclic guanosine monophosphate (cGMP) in the corpus cavernosum, thereby improving erectile function in men [1] - The approval of this drug is significant as it addresses the treatment of male erectile dysfunction, a condition that affects a substantial portion of the male population [1]